Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 11 patents
2 readers on Mendeley
  • Article usage
  • Citations to this article (113)

Advertisement

Research Article Free access | 10.1172/JCI106545

The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon

Lois B. Epstein, Martin J. Cline, and Thomas C. Merigan

Cancer Research Institute and the Department of Medicine, University of California, San Francisco, California 94122

Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California 94304

Find articles by Epstein, L. in: JCI | PubMed | Google Scholar

Cancer Research Institute and the Department of Medicine, University of California, San Francisco, California 94122

Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California 94304

Find articles by Cline, M. in: JCI | PubMed | Google Scholar

Cancer Research Institute and the Department of Medicine, University of California, San Francisco, California 94122

Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California 94304

Find articles by Merigan, T. in: JCI | PubMed | Google Scholar

Published April 1, 1971 - More info

Published in Volume 50, Issue 4 on April 1, 1971
J Clin Invest. 1971;50(4):744–753. https://doi.org/10.1172/JCI106545.
© 1971 The American Society for Clinical Investigation
Published April 1, 1971 - Version history
View PDF
Abstract

In studies of 13 normal adults to determine the blood cell types responsible for interferon production induced by phytohemagglutinin, the following observations were made. (a) In cultures containing 96-100% pure macrophages derived from blood monocytes, no interferon was detected in either the presence or the absence of phytohemagglutinin for up to 92 hr. (b) In cultures of 99.5-100% pure lymphocytes, low levels of interferon were detected in the presence, but not in the absence, of phytohemagglutinin. (c) An average fivefold increase in interferon titers occurred when pure lymphocytes were combined with the macrophages in culture with phytohemagglutinin. The peak response of interferon occurred at 68 hr after the initiation of the combined cultures. For maximum response, phytohemagglutinin was required for the duration of the culture, and both cell types in association were necessary. Medium from phytohemagglutinin-stimulated macrophages or lymphocytes could not substitute for the corresponding intact cell. However, frozen-thawed macrophages in combination with lymphocytes and phytohemagglutinin produced an intermediate interferon response. An increase in either cell type produced an increased response in the range studied: lymphocytes, 0.45-1.8 × 106 per ml; and macrophages, 0.5-2.1 × 105 per ml. Syngeneic fibroblasts, HeLa cells, or mouse macrophages could not substitute for the human macrophages in the combined cultures with phytohemagglutinin. (d) Although all cultures producing interferon showed some degree of transformation (thymidine-3H incorporation into deoxyribonucleic acid), no direct correlation between the degree of phytohemagglutinin-induced lymphocyte transformation and the interferon titers was observed.

The demonstration of macrophage-lymphocyte interaction in the production of interferon is of interest in view of the known interrelationship of these same cell types in antibody synthesis and cellular immunity.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 744
page 744
icon of scanned page 745
page 745
icon of scanned page 746
page 746
icon of scanned page 747
page 747
icon of scanned page 748
page 748
icon of scanned page 749
page 749
icon of scanned page 750
page 750
icon of scanned page 751
page 751
icon of scanned page 752
page 752
icon of scanned page 753
page 753
Version history
  • Version 1 (April 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (113)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 11 patents
2 readers on Mendeley
See more details